Can the addition of cetuximab to irinotecan improve outcome in colorectal cancer? View Full Text


Ontology type: schema:ScholarlyArticle     

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/ncpgasthep0066

DOI

http://dx.doi.org/10.1038/ncpgasthep0066

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1038285981

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/16265095


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1101", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical Biochemistry and Metabolomics", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adenocarcinoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adolescent", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibodies, Monoclonal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibodies, Monoclonal, Humanized", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Camptothecin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cetuximab", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Colorectal Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "DNA Topoisomerases, Type I", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease Progression", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Therapy, Combination", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Follow-Up Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Irinotecan", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "an Oncologist at the Medical Oncology Unit, San Carlo Hospital, Potenza, Italy", 
          "id": "http://www.grid.ac/institutes/grid.416325.7", 
          "name": [
            "an Oncologist at the Medical Oncology Unit, San Carlo Hospital, Potenza, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rosati", 
        "givenName": "Gerardo", 
        "id": "sg:person.01362033743.92", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01362033743.92"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2005-01", 
    "datePublishedReg": "2005-01-01", 
    "genre": "article", 
    "id": "sg:pub.10.1038/ncpgasthep0066", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1294865", 
        "issn": [
          "1759-5045", 
          "1759-5053"
        ], 
        "name": "Nature Reviews Gastroenterology & Hepatology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "2"
      }
    ], 
    "keywords": [
      "addition of cetuximab", 
      "colorectal cancer", 
      "cetuximab", 
      "irinotecan", 
      "cancer", 
      "outcomes", 
      "addition"
    ], 
    "name": "Can the addition of cetuximab to irinotecan improve outcome in colorectal cancer?", 
    "pagination": "20-21", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1038285981"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/ncpgasthep0066"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "16265095"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/ncpgasthep0066", 
      "https://app.dimensions.ai/details/publication/pub.1038285981"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2021-12-01T19:16", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211201/entities/gbq_results/article/article_396.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/ncpgasthep0066"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/ncpgasthep0066'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/ncpgasthep0066'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/ncpgasthep0066'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/ncpgasthep0066'


 

This table displays all metadata directly associated to this object as RDF triples.

132 TRIPLES      20 PREDICATES      49 URIs      40 LITERALS      22 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/ncpgasthep0066 schema:about N1d613a16e96e4987bb89b7f37cdfd3bc
2 N2af4c3b076f146879fecfe7309f2fde4
3 N2de331dec40c4aec8ca989a915a3d85e
4 N2f32533d6e4e423ca3320dfccc6fbfb9
5 N3aef3c3da907424d99138e4536951a64
6 N5717dad5131a4ad59665bfb01cf31df7
7 N699079031e8a472c88e8d6e3aae5f119
8 N72b3fcf53dc44a39a8bfe5909dc3cdae
9 N7a2f5122ecb249c39ef7fddb48db8aae
10 Naaa89220e5624090b75012e0c62fab2f
11 Nb87ed7b5b4b844ad9d00b8ff7ed96dc2
12 Nbd415d59aa7a4118bdd781be53dc11fb
13 Nd00ede98a0f0405e86793c4ce0f46012
14 Ndbc60cc6626a46548db3a76d74c7d817
15 Nf276dc3d114f4f6083f3fd22c25c0fe2
16 anzsrc-for:11
17 anzsrc-for:1101
18 anzsrc-for:1103
19 schema:author N7ac3a44190e54dd5ad638e322c96af6e
20 schema:datePublished 2005-01
21 schema:datePublishedReg 2005-01-01
22 schema:genre article
23 schema:inLanguage en
24 schema:isAccessibleForFree false
25 schema:isPartOf N1cb813f8e9b4486a9e7dbff7af0bdf4b
26 Nd0e508ede18241c89a1c1b930889b28f
27 sg:journal.1294865
28 schema:keywords addition
29 addition of cetuximab
30 cancer
31 cetuximab
32 colorectal cancer
33 irinotecan
34 outcomes
35 schema:name Can the addition of cetuximab to irinotecan improve outcome in colorectal cancer?
36 schema:pagination 20-21
37 schema:productId N536c9952b3664825a7f504a2fb0add68
38 N59554617c7d6444e88ab24747b5bbf2b
39 N6df64b3a6f9f49eb853356f69b213f82
40 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038285981
41 https://doi.org/10.1038/ncpgasthep0066
42 schema:sdDatePublished 2021-12-01T19:16
43 schema:sdLicense https://scigraph.springernature.com/explorer/license/
44 schema:sdPublisher Ne843da3b9203481a8aabc589c150ed3b
45 schema:url https://doi.org/10.1038/ncpgasthep0066
46 sgo:license sg:explorer/license/
47 sgo:sdDataset articles
48 rdf:type schema:ScholarlyArticle
49 N1cb813f8e9b4486a9e7dbff7af0bdf4b schema:volumeNumber 2
50 rdf:type schema:PublicationVolume
51 N1d613a16e96e4987bb89b7f37cdfd3bc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
52 schema:name Irinotecan
53 rdf:type schema:DefinedTerm
54 N2af4c3b076f146879fecfe7309f2fde4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
55 schema:name Follow-Up Studies
56 rdf:type schema:DefinedTerm
57 N2de331dec40c4aec8ca989a915a3d85e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
58 schema:name DNA Topoisomerases, Type I
59 rdf:type schema:DefinedTerm
60 N2f32533d6e4e423ca3320dfccc6fbfb9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
61 schema:name Disease Progression
62 rdf:type schema:DefinedTerm
63 N3aef3c3da907424d99138e4536951a64 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
64 schema:name Colorectal Neoplasms
65 rdf:type schema:DefinedTerm
66 N536c9952b3664825a7f504a2fb0add68 schema:name dimensions_id
67 schema:value pub.1038285981
68 rdf:type schema:PropertyValue
69 N5717dad5131a4ad59665bfb01cf31df7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
70 schema:name Camptothecin
71 rdf:type schema:DefinedTerm
72 N59554617c7d6444e88ab24747b5bbf2b schema:name doi
73 schema:value 10.1038/ncpgasthep0066
74 rdf:type schema:PropertyValue
75 N699079031e8a472c88e8d6e3aae5f119 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
76 schema:name Humans
77 rdf:type schema:DefinedTerm
78 N6df64b3a6f9f49eb853356f69b213f82 schema:name pubmed_id
79 schema:value 16265095
80 rdf:type schema:PropertyValue
81 N72b3fcf53dc44a39a8bfe5909dc3cdae schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
82 schema:name Treatment Outcome
83 rdf:type schema:DefinedTerm
84 N7a2f5122ecb249c39ef7fddb48db8aae schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
85 schema:name Adolescent
86 rdf:type schema:DefinedTerm
87 N7ac3a44190e54dd5ad638e322c96af6e rdf:first sg:person.01362033743.92
88 rdf:rest rdf:nil
89 Naaa89220e5624090b75012e0c62fab2f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
90 schema:name Cetuximab
91 rdf:type schema:DefinedTerm
92 Nb87ed7b5b4b844ad9d00b8ff7ed96dc2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
93 schema:name Drug Therapy, Combination
94 rdf:type schema:DefinedTerm
95 Nbd415d59aa7a4118bdd781be53dc11fb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Adenocarcinoma
97 rdf:type schema:DefinedTerm
98 Nd00ede98a0f0405e86793c4ce0f46012 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
99 schema:name Antibodies, Monoclonal, Humanized
100 rdf:type schema:DefinedTerm
101 Nd0e508ede18241c89a1c1b930889b28f schema:issueNumber 1
102 rdf:type schema:PublicationIssue
103 Ndbc60cc6626a46548db3a76d74c7d817 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Antibodies, Monoclonal
105 rdf:type schema:DefinedTerm
106 Ne843da3b9203481a8aabc589c150ed3b schema:name Springer Nature - SN SciGraph project
107 rdf:type schema:Organization
108 Nf276dc3d114f4f6083f3fd22c25c0fe2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
109 schema:name Antineoplastic Agents
110 rdf:type schema:DefinedTerm
111 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
112 schema:name Medical and Health Sciences
113 rdf:type schema:DefinedTerm
114 anzsrc-for:1101 schema:inDefinedTermSet anzsrc-for:
115 schema:name Medical Biochemistry and Metabolomics
116 rdf:type schema:DefinedTerm
117 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
118 schema:name Clinical Sciences
119 rdf:type schema:DefinedTerm
120 sg:journal.1294865 schema:issn 1759-5045
121 1759-5053
122 schema:name Nature Reviews Gastroenterology & Hepatology
123 schema:publisher Springer Nature
124 rdf:type schema:Periodical
125 sg:person.01362033743.92 schema:affiliation grid-institutes:grid.416325.7
126 schema:familyName Rosati
127 schema:givenName Gerardo
128 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01362033743.92
129 rdf:type schema:Person
130 grid-institutes:grid.416325.7 schema:alternateName an Oncologist at the Medical Oncology Unit, San Carlo Hospital, Potenza, Italy
131 schema:name an Oncologist at the Medical Oncology Unit, San Carlo Hospital, Potenza, Italy
132 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...